From GlobeNewswire

Teva’s Pivot to Growth Strategy Delivers 33% Growth Across Key Innovative Brands; Raises 2026 Outlook for AUSTEDO®, AJOVY® and UZEDY®; Delivers Substantial Gross Margin Expansion

COMPANY STRENGTHENS NEUROSCIENCE LEADERSHIP WITH WELTRUZA™ LAUNCH AND STRATEGIC ADDITION OF BXCL-501

Spider Digital Technology Ltd. and Starlink AI Acquisition Corporation Announce Definitive Business Combination Agreement

Proposed transaction would take Spider Digital’s cryptocurrency mining pool business public in the United States

Brookfield and CPP Investments Complete Acquisition of LXP Industrial Trust

Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option and Appointment of Fred Hassan as Chair

•New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden reductions in…

Intuitive Appoints Aaron Martin to its Board of Directors

Syndax Reports Third Quarter 2026 Financial Results and Provides Business Update

Total revenue of $83.3 million in 3Q26, an 82% year-over-year increase –

Greenlane Appoints Peter Kampian to its Board of Directors

Experienced public company chief financial officer and director brings financial reporting and capital markets expertise

Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.

- Theriva received a $350,000 upfront payment at closing and is eligible for up to $91 million in regulatory and sales milestones, along with low…